Financials PDS Limited Bombay S.E.

Equities

PDSL

INE111Q01021

Apparel & Accessories

Market Closed - Bombay S.E. Other stock markets 03:30:48 10/05/2024 pm IST			5-day change	1st Jan Change
439.9 ^INR	+0.80%		+0.03%	-20.57%

10/05	NetScientific says PDS Biotech's Versamune meets endpoints	AN
10/05	PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study	MT

Valuation

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	7,348	17,252	45,504	43,488	58,020	-	-
Enterprise Value (EV) ¹	7,348	17,252	45,089	43,488	58,020	58,020	58,020
P/E ratio	16 x	20.5 x	18.5 x	16.7 x	26.8 x	18.2 x	13.9 x
Yield	-	-	1.37%	0.78%	0.36%	1.39%	1.8%
Capitalization / Revenue	0.11 x	-	0.52 x	0.41 x	0.56 x	0.47 x	0.4 x
EV / Revenue	0.11 x	-	0.52 x	0.41 x	0.56 x	0.47 x	0.4 x
EV / EBITDA	3.46 x	-	14.1 x	9.47 x	12.2 x	9.97 x	8.23 x
EV / FCF	-	-	12.7 x	8.58 x	-89 x	26.7 x	23.9 x
FCF Yield	-	-	7.87%	11.7%	-1.12%	3.74%	4.18%
Price to Book	1.32 x	-	4.86 x	-	4.62 x	3.88 x	3.21 x
Nbr of stocks (in thousands)	1,30,234	1,30,234	1,30,234	1,30,928	1,32,045	-	-
Reference price ²	56.42	132.5	349.4	332.2	439.4	439.4	439.4
Announcement Date	10/07/20	27/05/21	16/05/22	11/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	66,480	-	88,282	1,05,770	1,04,529	1,22,768	1,46,066
EBITDA ¹	2,125	-	3,226	4,592	4,749	5,821	7,054
EBIT ¹	-	-	2,526	3,790	3,885	4,927	6,135
Operating Margin	-	-	2.86%	3.58%	3.72%	4.01%	4.2%
Earnings before Tax (EBT) ¹	974.4	-	3,101	3,568	3,094	4,527	5,930
Net income ¹	460.2	843.2	2,484	2,650	2,157	3,175	4,159
Net margin	0.69%	-	2.81%	2.51%	2.06%	2.59%	2.85%
EPS ²	3.534	6.474	18.86	19.93	16.40	24.20	31.70
Free Cash Flow ¹	-	-	3,583	5,071	-652	2,169	2,424
FCF margin	-	-	4.06%	4.79%	-0.62%	1.77%	1.66%
FCF Conversion (EBITDA)	-	-	111.07%	110.44%	-	37.26%	34.36%
FCF Conversion (Net income)	-	-	144.22%	191.38%	-	68.31%	58.28%
Dividend per Share ²	-	-	4.770	2.600	1.600	6.100	7.900
Announcement Date	10/07/20	27/05/21	16/05/22	11/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2023 Q1	2023 Q2
Net sales ¹	23,404	29,212
EBITDA ¹	730.8	1,192
EBIT	-	-
Operating Margin	-	-
Earnings before Tax (EBT)	-	-
Net income	-	-
Net margin	-	-
EPS	-	-
Dividend per Share	-	-
Announcement Date	01/08/22	02/11/22

¹INR in Million

Estimates

Balance Sheet Analysis

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-
Net Cash position	-	-	415	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	3,583	5,071	-652	2,169	2,424
ROE (net income / shareholders' equity)	9.04%	-	30.1%	27.5%	18.7%	23.2%	25.3%
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-
Book Value Per Share ²	42.90	-	71.90	-	95.10	113.0	137.0
Cash Flow per Share	-	-	-	-	-	-	-
Capex ¹	-	-	380	-	735	800	850
Capex / Sales	-	-	0.43%	-	0.7%	0.65%	0.58%
Announcement Date	10/07/20	27/05/21	16/05/22	11/05/23	-	-	-

¹INR in Million²INR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for PDS Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

439.4 INR

Average target price

950 INR

Spread / Average Target

+116.20%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Apparel & Accessories

	1st Jan change	Capi.
CHRISTIAN DIOR SE	+4.59%	144B
LULULEMON ATHLETICA INC.	-30.97%	44.44B
MONCLER S.P.A.	+13.90%	18.47B
RALPH LAUREN CORPORATION	+15.92%	10.69B
LEVI STRAUSS & CO.	+36.76%	9B
LI NING COMPANY LIMITED	+6.70%	7.23B
PVH CORP.	-6.64%	6.45B
BOSIDENG INTERNATIONAL HOLDINGS LIMITED	+30.48%	6.39B
GILDAN ACTIVEWEAR INC.	+4.82%	5.67B

Other Apparel & Accessories